Madrigal Pharmaceuticals, Inc. Share Price
Stocks
MDGL
US5588681057
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 474.18 USD | -13.29% |
|
+1.72% | -6.09% |
| Market Cap | 1.26TCr 1.11TCr 1.03TCr 949.09Cr 1.78TCr 1,20800Cr 1.82TCr 12TCr 4.8TCr 60TCr 4.73TCr 4.63TCr 2,06600Cr | P/E 2026 * |
-77.7x | P/E 2027 * | 65.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.21TCr 1.06TCr 991.91Cr 910.32Cr 1.7TCr 1,15800Cr 1.75TCr 12TCr 4.6TCr 57TCr 4.54TCr 4.44TCr 1,98200Cr | EV / Sales 2026 * |
8.05x | EV / Sales 2027 * | 5.3x |
| Free-Float |
94.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | -13.33% | ||
| 1 week | +1.72% | ||
| Current month | +1.85% | ||
| 1 month | +3.72% | ||
| 3 months | +5.46% | ||
| 6 months | +10.55% | ||
| Current year | -6.09% |
| 1 week | 532.96 |  | 566.18 |
| 1 month | 507.6 | | 569.44 |
| Current year | 416.21 | | 598.79 |
| 1 year | 290 | | 615 |
| 3 years | 119.76 | | 615 |
| 5 years | 52.33 | | 615 |
| 10 years | 6.6 | | 615 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 08/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 11/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 21/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 01/07/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 11/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 27/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/07/26 | Sell | Chief Executive Officer | -2,500 | 0.0108% | ||
| 17/06/26 | Free | Director | 1,220 | 0.0053% | ||
| 23/02/26 | Fiscal year | Director | 5,000 | 0.0220% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -13.29% | +1.72% | +85.76% | +166.11% | 1.26TCr | |
| -3.61% | -6.02% | +43.16% | +63.89% | 5.52TCr | |
| +2.83% | +0.48% | +28.18% | +82.59% | 5.56TCr | |
| -0.70% | +1.22% | -16.62% | -13.47% | 2.35TCr | |
| -2.03% | -3.30% | -1.79% | +383.00% | 2.24TCr | |
| -4.01% | -3.67% | +13.17% | -14.29% | 2.06TCr | |
| -2.38% | -3.70% | +25.28% | -34.21% | 1.74TCr | |
| -3.34% | -7.77% | +23.78% | +536.66% | 1.52TCr | |
| -1.17% | +0.64% | +49.78% | +178.74% | 1.39TCr | |
| -3.14% | -8.47% | +165.37% | +292.18% | 1.37TCr | |
| Average | -3.07% | -1.29% | +41.61% | +164.12% | 2.5TCr | |
| Weighted average by Cap. | -1.98% | -0.56% | +34.53% | +128.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 150.31Cr 132.08Cr 123.29Cr 113.14Cr 211.8Cr 14TCr 217.02Cr 1.46TCr 571.73Cr 7.12TCr 564.35Cr 552.1Cr 25TCr | 217.45Cr 191.07Cr 178.35Cr 163.68Cr 306.4Cr 21TCr 313.95Cr 2.11TCr 827.09Cr 10TCr 816.41Cr 798.69Cr 36TCr |
| Net income | -20Cr -17Cr -16Cr -15Cr -28Cr -1.89TCr -28Cr -191.47Cr -75Cr -933.07Cr -74Cr -72Cr -3.23TCr | 27Cr 24Cr 22Cr 20Cr 38Cr 2.58TCr 39Cr 261.9Cr 102.42Cr 1.28TCr 101.1Cr 99Cr 4.41TCr |
| Net Debt | -52Cr -45Cr -42Cr -39Cr -73Cr -4.93TCr -74Cr -501.03Cr -195.94Cr -2.44TCr -193.41Cr -189.21Cr -8.44TCr | -107.6Cr -95Cr -88Cr -81Cr -151.62Cr -10TCr -155.35Cr -1.05TCr -409.27Cr -5.1TCr -403.99Cr -395.22Cr -18TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $546.88 | +1.50% | 3,56,878 |
| 28/26/28 | $538.80 | -2.26% | 2,18,771 |
| 27/26/27 | $551.25 | +1.24% | 2,68,615 |
| 24/26/24 | $544.51 | +0.21% | 1,47,390 |
| 23/26/23 | $543.35 | +1.06% | 1,60,514 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
Select your edition
All financial news and data tailored to specific country editions
